Agios plans mitapivat sickle cell disease filing after FDA meeting

March 31, 2026 7:01 AM

Agios Pharmaceuticals Inc. (NASDAQ: AGIO) plans to submit a supplemental new drug application for mitapivat in sickle cell disease following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found